Obstructive and Central Sleep Apnoea

This book will be published in September 2026. Pre-ordered copies will be dispatched upon publication. Edited by Winfried Randerath, Jean-Louis Pepin and Sophia Schiza Contents list (subject to change) 1. Patients' perspective 2. Obesity, environment, global warming: current epidemiology and perspectives in modulating SDB burden in 2050 3. The impact of obesity: obstruction, inflammation, endocrine function 4. The pathophysiological traits: what do we know? What do we miss? 5. Mechanisms, biomarkers and clinical manifestations of vascular damage 6. OSA and oncogenesis – is there evidence? 7. Patient-reported outcomes, daytime performance, and neuro-psychiatric symptoms 8. AHI, hypoxia, autonomic arousals, pulse wave, heart rate variability: what does matter? 9. OSA in females 10. Cluster analysis: relevance for phenotyping and outcome 11. OSA and insomnia (COMISA) 12. COPD-OSA overlap, IPF-OSA 13. Obesity hypoventilation 14. Integrative concepts of classification and treatment decision 15. Technological innovations and artificial intelligence for end-to-end diagnostical, treatment and follow-up pathways 16. Wearables, single-channel screening, polygraphy, polysomnography: why, were, how? 17. Multiple-night diagnosis: a revolution in the field? 18. Obesity management: behaviour, drugs, surgery 19. Positive airway pressure (PAP) therapies – indication, selection and management 20. Non-PAP therapies: from orthodontics to surgery 21. Towards a new area: pharmaceutical treatments and combination therapy 22. Epidemiology, entities and pathophysiological concepts 23. Diagnostical tools (differentiation of hypopnoeas, hypercapnic/hypoxic chemoresponsiveness) 24. Treatment: oxygen, drugs, PAP Print ISBN: 978-1-84984-214-3 eISBN: 978-1-84984-215-0 EPUB ISBN: 978-1-84984-216-7